Stay updated on PF-06650833/PF-06700841/PF-06826647 in Hidradenitis Suppurativa Clinical Trial
Sign up to get notified when there's something new on the PF-06650833/PF-06700841/PF-06826647 in Hidradenitis Suppurativa Clinical Trial page.

Latest updates to the PF-06650833/PF-06700841/PF-06826647 in Hidradenitis Suppurativa Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed, indicating a minor update to the page's revision history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedExpanded the Locations section to list study sites across multiple US states (Alabama, Arizona, California, Connecticut, Florida, Georgia, Illinois, Indiana, Kentucky, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, Nevada, New York, Oklahoma, Pennsylvania, Tennessee, Texas, Utah, Virginia, Washington) and international sites in Australia (Australian Capital Territory, New South Wales, Queensland, Victoria) and Canada (Ontario, Quebec). The HHS Vulnerability Disclosure link was removed.SummaryDifference2%

- Check68 days agoChange DetectedThe Publications section now notes that publications are automatically filled from PubMed, and the revision tag has been updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check75 days agoChange DetectedRemoved the general government funding/status banner from the page. The study details, eligibility criteria, and primary outcomes remain unchanged.SummaryDifference0.2%

- Check96 days agoChange DetectedNo significant changes detected between the two screenshots of the Study Details page; only minor cosmetic formatting adjustments are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check118 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference2%

Stay in the know with updates to PF-06650833/PF-06700841/PF-06826647 in Hidradenitis Suppurativa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06650833/PF-06700841/PF-06826647 in Hidradenitis Suppurativa Clinical Trial page.